Evidence map›Paper›PMID 36848429›Full record

ReviewStroke2023

Vascular Biology of Dementia.

Marilyn J Cipolla, Nabil J Alkayed

Abstract readReview
In one paragraph

Review in Stroke, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. The interaction between dysfunction of vasculature and tauopathy in Alzheimer's disease and related dementias.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Marilyn J CipollaDepartment of Neurological Sciences, University of Vermont Larner College of Medicine, Burlington (M.J.C.).ORCID 0000-0002-9172-5941
Nabil J AlkayedDepartment of Anesthesiology & Perioperative Medicine and Knight Cardiovascular Institute, Portland, OR (N.J.A.).ORCID 0000-0002-3489-4730

Funding

Neuroinflammatory Mechanisms of Vascular Cognitive ImpairmentRF1AG058273 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALKAYED, NABIL J · 2017 to 2023
$4.2M
Role of GPR39 in Aging-Related Vascular Cognitive Impairment (VCI)RF1AG076158 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALKAYED, NABIL J · 2022 to 2025
$3.3M
GPR39 as a Therapeutic Target in Aging-Related Vascular Cognitive Impairment and DementiaRF1AG079890 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALKAYED, NABIL J · 2023 to 2023
$2.2M
Soluble Epoxide Hydrolase Inhibitor GSK2256294 for Acute Ischemic StrokeU01NS132345 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALKAYED, NABIL J · 2023 to 2025
$994k
NIA NIH HHS RF1 AG058273NIA NIH HHS RF1 AG076158NIA NIH HHS RF1 AG079890NINDS NIH HHS U01 NS132345
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DementiaBiologyHumansblood-brain barriercarotid stenosiscognitive disordersdementiaheart disease

Identifiers

PMID36848429
PMCPMC12369311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.